My watch list
my.bionity.com  
Login  

37 Current news about the topic neck cancer

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
A big step toward stopping cancer metastasis

12-Feb-2018

New research from The Scripps Research Institute (TSRI) may give scientists a chance to target tumors before they metastasize. The study shows that a protein called LTBP3 fuels a chain reaction that leads some early developing tumors to grow new blood vessels. These vessels then act like highways ...

more

Chemoradiation may increase survival for a subset of elderly cancer patients

19-Feb-2016

The addition of chemotherapy (CT) to radiation therapy (RT) improves survival rates among a subset of elderly head and neck cancer patients, specifically those ages 71 to 79 with low comorbidity scores and advanced disease stage, according to University of Colorado Cancer Center research ...

more

Scientists identify DNA alterations as among earliest to occur in lung cancer development

23-Sep-2015

Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest "premalignant" genetic changes that mark the potential onset of the most common and deadliest form of ...

more

Imaging method has potential to stratify head and neck cancer patients

22-Sep-2015

Researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy. These patients commonly receive pre-treatment induction chemotherapy, before either surgery or radiotherapy, to reduce the risk of disease spread. However the ...

more

Researchers home in on way to predict aggressiveness of oral cancer

02-Jul-2014

Studying mouth cancer in mice, researchers have found a way to predict the aggressiveness of similar tumors in people, an early step toward a diagnostic test that could guide treatment, according to researchers at Washington University School of Medicine in St. Louis. "All patients with advanced ...

more

Nano-capsules show potential for more potent chemoprevention

09-Jan-2014

Researchers at the Winship Cancer Institute of Emory University have discovered a more effective drug delivery system using nanotechnology that could one day significantly affect cancer prevention. The study, published in Cancer Prevention Research, a journal of the American Association for ...

more

Proton therapy cuts side effects

26-Sep-2013

The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the ...

more

Sentinel node biopsy safe, effective in head and neck melanomas, U-M study finds

Study refutes controversy about technique in delicate head, neck region

10-Aug-2011

A common technique for determining whether melanoma has spread can be used safely and effectively even in tumors from the head and neck area, according to a new study from the University of Michigan Comprehensive Cancer Center. Sentinel lymph node biopsy involves injecting a special dye to ...

more

CT Atlantic AG Announces Appointment of Thomas Lander to the Board of Directors

16-Sep-2010

CT Atlantic AG announced the appointment of Dr. Thomas Lander to its board of directors. Thomas Lander provides CT Atlantic with long-standing, global pharmaceutical experience in early through late stage drug development and in regulatory affairs. Dr. Lander was previously Managing Director of ...

more

Idera Pharmaceuticals Achieves Clinical Milestone Under Its Collaboration with Merck KGaA for Cancer Treatment

Clinical Trial Initiated in First-Line Treatment of Patients with Head and Neck Cancer

31-Aug-2010

Idera Pharmaceuticals, Inc. announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA. The milestone was achieved upon Merck KGaA’s initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 ...

more

Page 1 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE